Tom Frohlich is Chief Executive Officer, President and Director of Jade Biosciences, Inc. (JBIO). The company reported total compensation of $9,799,759 for fiscal year 2025.
| Salary | $621,970 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $8,779,876 |
| Non-equity incentive plan | $397,913 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $9,799,759 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Jade Biosciences, Inc. filed April 28, 2026, accession 0001193125-26-187059.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer, President and Director | $621,970 | $0 | $0 | $8,779,876 | $397,913 | $0 | $0 | $9,799,759 |
| FY2024 | Chief Executive Officer, President and Director | $146,920 | $0 | $0 | $1,121,312 | $96,164 | $0 | $0 | $1,364,396 |
Totals as disclosed in each year's own compensation disclosure for Jade Biosciences, Inc..
| Peer-group chief executive median | $4,661,000 |
|---|---|
| Difference from that median | $5,138,759 |
| Percentile within the disclosed peer group | 88th |
| Peers with a disclosed figure | 17 |
Medians and percentiles are computed across the peer group Jade Biosciences, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Tom Frohlich this page | Chief Executive Officer, President and Director | $9,799,759 |
| Andrew King | President, Research and Development | $4,541,804 |
| Bradford Dahms | Chief Financial Officer | $4,131,991 |
| Timothy Noyes | Former Chief Executive Officer | $1,814,483 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Jade Biosciences, Inc. compensation brief.
Tom Frohlich's compensation sits inside Jade Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.